OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
There is still no structured method of assessing pricing and access risk for drug manufacturers. Presented here is a straightforward measure for
integrating pricing and access risk into portfolio planning and decision-making.